How many shares of RARE does BNP PARIBAS FINANCIAL MARKETS own?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 498,167 shares of RARE (Ultragenyx Pharmaceutical, Inc.).

What is BNP PARIBAS FINANCIAL MARKETS's RARE position worth?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's RARE position is worth $16.6M.

Is BNP PARIBAS FINANCIAL MARKETS buying or selling RARE?

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS increased their RARE position (+1.5% change in shares).

When did BNP PARIBAS FINANCIAL MARKETS first buy RARE?

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in RARE in 2018-Q4. They have held the position across 31 quarters.

Back to

BNP PARIBAS FINANCIAL MARKETS

RARE
31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in Ultragenyx Pharmaceutical, Inc.

Current Value

$16.6M

Current Shares

498,167

Total Value Change

+$16.1M

Total Shares Change

+486,030

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	498,167	+1.5%	$16.6M	0.0%	$33.39	29
2026-Q1	Decreased	490,783	-45.6%	$10.3M	0.0%	$22.07	0
2025-Q4	Increased	903,050	+57.6%	$20.8M	0.0%	$22.78	41
2025-Q3	Increased	573,019	+153.7%	$17.2M	0.0%	$30.36	46
2025-Q2	Increased	225,826	+27.7%	$8.2M	0.0%	$36.52	34
2025-Q1	Increased	176,851	+24.0%	$6.4M	0.0%	$37.82	33
2024-Q4	Increased	142,628	+394.7%	$6M	0.0%	$42.27	44
2024-Q3	Decreased	28,831	-57.3%	$1.6M	0.0%	$54.43	0
2024-Q2	Increased	67,472	+239.2%	$2.8M	0.0%	$41.10	42
2024-Q1	Decreased	19,893	-87.3%	$928,804	0.0%	$46.69	0
2023-Q4	Decreased	157,281	-26.6%	$7.5M	0.0%	$47.82	0
2023-Q3	Increased	214,275	+38.3%	$7.6M	0.0%	$35.65	36
2023-Q2	Increased	154,963	+57.3%	$7.1M	0.0%	$46.65	39
2023-Q1	Increased	98,528	+65.8%	$4M	0.0%	$38.64	39
2022-Q4	Decreased	59,424	-10.0%	$2.8M	0.0%	$46.33	0
2022-Q3	Increased	65,997	+344.4%	$2.7M	0.0%	$40.55	42
2022-Q2	Decreased	14,849	-13.9%	$885,891	0.0%	$60.24	0
2022-Q1	Decreased	17,249	-63.2%	$1.3M	0.0%	$71.36	0
2021-Q4	Increased	46,820	+363.1%	$3.9M	0.0%	$84.25	43
2021-Q3	Increased	10,109	+36.0%	$911.7M	0.0%	$86.12	41
2021-Q2	Decreased	7,436	-80.7%	$709,023	0.0%	$96.29	0
2021-Q1	Increased	38,549	+113.1%	$4.4M	0.0%	$112.06	43
2020-Q4	Decreased	18,088	-47.9%	$2.5M	0.0%	$144.37	0
2020-Q3	Increased	34,693	+104.0%	$2.9M	0.0%	$85.10	42
2020-Q2	Decreased	17,008	-57.3%	$1.3M	0.0%	$73.66	0
2020-Q1	Increased	39,832	+84.9%	$1.8M	0.0%	$44.32	40
2019-Q4	Increased	21,546	+3.8%	$920,230	0.0%	$42.69	26
2019-Q3	Increased	20,758	+19.4%	$888,027	0.0%	$42.50	29
2019-Q2	Decreased	17,392	-31.2%	$1.1M	0.0%	$63.50	0
2019-Q1	Increased	25,295	+108.4%	$1.8M	0.0%	$69.36	42
2018-Q4	New	12,137	-	$527,717	0.0%	$41.87	33

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

RARE31 quarters

RARE
31 quarters